ArticleFrontiers in public health2026
Study on the reform effect of payment based on curative effect value for TCM dominant diseases in China: an interrupted time series analysis.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anorectal diseases, as prevalent and recurrent conditions for which Traditional Chinese Medicine (TCM) demonstrates distinct advantages, are closely associated with patients' quality of life. The current Diagnosis-Related Group (DRG) payment system struggles to fully capture the unique value of TCM, whereas Value-Based payment models grounded in therapeutic efficacy offered a viable pathway for reforming payment mechanisms for TCM-dominant diseases. Methods: This study included a total of 5,304 patients diagnosed with hemorrhoids, anal fistulas, and other anorectal diseases who were admitted to the Proctology Department of a tertiary hospital in Hunan Province from August 2022 to August 2024. Interrupted Time Series (ITS) analysis was conducted, featuring two intervention points: January 2023 (DRG reform) and September 2023 (Value-Based payment reform). Nine indicators spanning three dimensions-Resource consumption (average inpatient cost per case, average length of stay), Cost structure (average TCM preparation cost per case, average TCM drug cost per case, average TCM diagnostic and treatment cost per case) and TCM characteristics (proportion of preparation cost in total drug revenue, proportion of TCM drug cost in total drug revenue, proportion of TCM diagnostic and treatment cost, proportion of discharged patients treated mainly with TCM)-were analyzed to evaluate both short-term and long-term effects of the dual policies, supplemented by age subgroup analysis. Results: After DRG reform, average inpatient cost per case (instantaneous decrease of CNY 1,131.27, Conclusion: Under the DRG framework, the Value-Based payment reform tied to therapeutic efficacy can effectively curb medical costs while incentivizing the application of TCM-specific services. Nevertheless, sustained monitoring is needed to evaluate its long-term impacts, particularly regarding age-related disparities in outcomes. These findings offer insights for refining TCM-inclusive medical insurance reimbursement policies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.